ANGELA HOEFT: Open Payments
NPI 1679808323 · CONIFER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 37 payments from 14 companies in 2025. Trend: 2023 $71 · 2024 $499 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $146 |
| Lilly USA, LLC | 6 | $99 |
| PFIZER INC. | 4 | $88 |
| ABBVIE INC. | 4 | $78 |
| Astellas Pharma US Inc | 3 | $63 |
| Grifols USA, LLC | 2 | $46 |
| Hologic Sales and Service, LLC | 2 | $45 |
| INOGEN, INC. | 1 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
Products named: SHINGRIX, MOUNJARO, Veozah, UBRELVY, Prolastin-C Liquid, PREVNAR 20, THINPREP 2000 PROCESSOR, NURTEC ODT.
Industry payments across CO — which companies pay providers there.
